SCHEMBL19975481

SCHEMBL19975481

COC(=O)c1ccccc1OCCCCCCCCCCCNC(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.52
CA1 P00915 5/20 0.52
CA2 P00918 5/20 0.52
CA9 Q16790 5/20 0.52
DRD2 P14416 4/20 0.52
HSP90AA1 P07900 2/20 0.49
MAPT P10636 2/20 0.49
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
ALDH1A1 P00352 2/20 0.47
HCRTR1 O43613 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL375401 0.91 SCN9A (0.50) CA12CA1CA2CA9DRD2
SCHEMBL23318052 0.90 PTPN1 (0.49) CA12CA1CA2CA9DRD2
SCHEMBL19979808 0.89 CA12 (0.53) CA12CA1CA2CA9DRD2
SCHEMBL2548980 0.86 CA12 (0.51) CA12CA1CA2CA9DRD2
SCHEMBL12514969 0.85 CA12 (0.54) CA12CA1CA2CA9DRD2
SCHEMBL9116472 0.85 ALDH1A1 (0.65) CA12CA1CA2CA9MAPT
SCHEMBL2551702 0.85 CA12 (0.50) CA12CA1CA2CA9DRD2
SCHEMBL20471820 0.84 CA12 (0.48) CA12CA1CA2CA9DRD2
SCHEMBL12603045 0.84 ALDH1A1 (0.56) CA12CA1CA2CA9DRD2
SCHEMBL19975104 0.83 DRD2 (0.47) CA12CA1CA2CA9DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018053302-A1 MACROCYCLIC COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY AND USE THEREOF ENSEMBLE THERAPEUTICS CORPORATION (US) 2018-03-22 WO disclosed
WO-2018053302-A1 MACROCYCLIC COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY AND USE THEREOF ENSEMBLE THERAPEUTICS CORPORATION (US) 2018-03-22 WO disclosed